Oruka Therapeutics (ORKA) executive compensation, 2026 proxy

Lawrence Klein, Chief Executive Officer, was paid $3.4M in 2025, up 544% from $520,911 the year before.

Filed
April 17, 2026
Annual meeting
June 2, 2026
Pay year
2025
Named executives
3
CEO total pay
$3.4M+544% vs prior year
CEO 2025 Total Pay
$3,356,050Significant increase from partial prior year
CEO Target Bonus
55%Percentage of base salary
Corporate Achievement
130%Based on 2025 corporate goals
CMO 2025 Total Pay
$2,338,593Joana Goncalves total compensation
General Counsel 2025 Total Pay
$2,338,593Paul Quinlan total compensation

How Klein was paid

$3.4M in total for 2025, as reported in the Summary Compensation Table. Equity awards are valued at grant, not at what they turned out to be worth.

Salary19%Option awards68%Non-equity incentive13%All other compensation0%

Named executive officers

ExecutiveTotal
Lawrence KleinChief Executive Officer$3,356,050
Joana GoncalvesChief Medical Officer$2,338,593
Paul QuinlanGeneral Counsel$2,338,593

What changed and why

  • $3.4MCEO Lawrence Klein received total compensation of $3,356,050 for 2025 compared to $520,911 for the prior year.
  • 130%Annual bonuses were awarded based on a corporate achievement level of 130% of target.
  • The 2025 equity awards consisted of stock options vesting monthly over four years.
  • Lawrence Klein received stock options to purchase 230,000 shares.

About this page

Figures are automated and can be wrong; check the filing for the exact numbers. Totals follow SEC rules, which value stock and option awards at grant. Read the DEF 14A proxy statement for footnotes and the compensation committee's full reasoning.